Lv1
96 积分 2026-03-12 加入
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
5天前
已完结
Iptacopan in IgA Nephropathy — Final 24-Month Data
5天前
已关闭
Iptacopan in IgA Nephropathy — Final 24-Month Data
5天前
已完结
Targeting CD20 versus APRIL or BAFF and APRIL for IgA Nephropathy
11天前
已完结
Glucocorticoid Receptor–Regulated Gene Networks and Mental Health
13天前
已关闭
Short- and Long-Term Outcomes of Mirikizumab for Ulcerative Colitis: A Real-World Multicenter Retrospective Cohort Study from the INSIGHT study
19天前
已关闭
Real-World Evidence - Where Are We Now?
19天前
已完结
Competition for Clinical Trials in Inflammatory Bowel Diseases
19天前
已完结
[A case of diversion colitis successfully treated with 5-aminosalicylic acid]
23天前
已关闭
皖公网安备34019202002308
